共 130 条
[1]
Napolitano M(2017)Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment Clin Cosmet Investig Dermatol 10 105-115
[2]
Megna M(2016)Adalimumab for the treatment of hidradenitis suppurativa/acne inversa Expert Rev Clin Immunol 12 1015-1026
[3]
Timoshchuk EA(2021)Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa J Allergy Clin Immunol 147 2213-2224
[4]
Zouboulis CC(2017)Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States JAMA Dermatol 153 760-764
[5]
Navrazhina K(2020)The epidemiology of hidradenitis suppurativa Br J Dermatol 183 990-998
[6]
Frew JW(2014)Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease Postgrad Med J 90 216-221
[7]
Gilleaudeau P(2022)Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US J Eur Acad Dermatol Venereol 36 1597-1605
[8]
Sullivan-Whalen M(2021)The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis Int J Environ Res Public Health 18 6709-478
[9]
Garcet S(2013)Depression in patients with hidradenitis suppurativa J Eur Acad Dermatol Venereol 27 473-1027
[10]
Krueger JG(2014)Hidradenitis suppurativa Best Pract Res Clin Obstet Gynaecol 28 1013-s41